Avanir Pharmaceuticals
Avanir Pharmaceuticals describe recent developments
Published in Healthcare Finance, Tax and Law Weekly, January 10th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Avanir Pharmaceuticals.
Report 1: Avanir Pharmaceuticals (AVNR) announced that it has received an approvable letter from the U.S. Food and Drug Administration (FDA) for Zenvia (formerly referred to as Neurodex) for the treatment of involuntary emotional expression disorder (IEED).
The company submitted a new drug application (NDA) in January 2006, seeking to market Zenvia for the treatment of IEED in patients with neurologic diseases and brain injuries. The communication from...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
More Articles from Healthcare Finance, Tax and Law Weekly
- Awards
Casey Family Programs announces Congressional Leadership Award recipient - Awards
DEAM wins LiveWIRE Young Business Award 2006 - Behavior
Researchers at University of Victoria target behavior - Behavior
Scientists at University of Nevada target behavior - Biotechnology
Data from Nanjing University of Finance and Economics advance knowledge in biotechnology - Business & Finance
Adolor discontinues sales force and reports other selected work force reductions - More from this issue of Healthcare Finance, Tax and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
